Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to WinZacks Investment Research • 10/01/26
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 CoverageZacks Investment Research • 07/01/26
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to GainZacks Investment Research • 05/19/26
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookZacks Investment Research • 02/04/26
ETFs in Focus as Competition Heats Up in Weight Loss Drug SegmentZacks Investment Research • 07/22/24